Global Anti-inflammatory Therapeutics Competitive Landscape Professional Research Report 2025

Global Anti-inflammatory Therapeutics Competitive Landscape Professional Research Report 2025



Research Summary

Anti-inflammatory therapeutics refer to drugs or drugs that are used to reduce inflammation and swelling in the body. These drugs work by targeting the immune system and reducing the production of inflammatory molecules, such as cytokines and prostaglandins, which cause inflammation and pain. Anti-inflammatory therapeutics are commonly used to treat a wide variety of conditions, including arthritis, asthma, inflammatory bowel disease, and skin conditions like psoriasis and eczema. They can be taken orally, topically, or by injection, and are available in a variety of forms including over-the-counter medications, prescription drugs, and biologics.

According to DIResearch's in-depth investigation and research, the global Anti-inflammatory Therapeutics market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Anti-inflammatory Therapeutics include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Sanofi, Merck, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Anti-inflammatory Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Anti-inflammatory Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Anti-inflammatory Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Anti-inflammatory Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Anti-inflammatory Therapeutics Include:

AbbVie

Johnson & Johnson

Amgen Inc

AstraZeneca PLC

Pfizer, Inc

Novartis

Roche

Sanofi

Merck

GlaxoSmithKline

Sun Pharmaceutical Industries Ltd

TEVA

Anti-inflammatory Therapeutics Product Segment Include:

Anti-inflammatory Biologics

Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

Corticosteroids

Others

Anti-inflammatory Therapeutics Product Application Include:

Arthritis

Respiratory Diseases

Dermatology

Gastroenterology

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Anti-inflammatory Therapeutics Industry PESTEL Analysis

Chapter 3: Global Anti-inflammatory Therapeutics Industry Porter’s Five Forces Analysis

Chapter 4: Global Anti-inflammatory Therapeutics Major Regional Market Size and Forecast Analysis

Chapter 5: Global Anti-inflammatory Therapeutics Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Anti-inflammatory Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Anti-inflammatory Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Anti-inflammatory Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Anti-inflammatory Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Anti-inflammatory Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Anti-inflammatory Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Anti-inflammatory Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Anti-inflammatory Therapeutics Market Overview
1.1 Product Definition and Statistical Scope
1.2 Anti-inflammatory Therapeutics Product by Type
1.2.1 Anti-inflammatory Biologics
1.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.2.3 Corticosteroids
1.2.4 Others
1.3 Anti-inflammatory Therapeutics Product by Application
1.3.1 Arthritis
1.3.2 Respiratory Diseases
1.3.3 Dermatology
1.3.4 Gastroenterology
1.3.5 Others
1.4 Global Anti-inflammatory Therapeutics Market Size Analysis (2020-2032)
1.5 Anti-inflammatory Therapeutics Market Development Status and Trends
1.5.1 Anti-inflammatory Therapeutics Industry Development Status Analysis
1.5.2 Anti-inflammatory Therapeutics Industry Development Trends Analysis
2 Anti-inflammatory Therapeutics Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Anti-inflammatory Therapeutics Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Anti-inflammatory Therapeutics Market Analysis by Regions
4.1 Anti-inflammatory Therapeutics Overall Market: 2024 VS 2025 VS 2032
4.2 Global Anti-inflammatory Therapeutics Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Anti-inflammatory Therapeutics Revenue and Market Share by Region (2020-2025)
4.2.2 Global Anti-inflammatory Therapeutics Revenue Forecast by Region (2026-2032)
5 Global Anti-inflammatory Therapeutics Market Size by Type and Application
5.1 Global Anti-inflammatory Therapeutics Market Size by Type (2020-2032)
5.2 Global Anti-inflammatory Therapeutics Market Size by Application (2020-2032)
6 North America
6.1 North America Anti-inflammatory Therapeutics Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Manufacturers Analysis
6.3 North America Anti-inflammatory Therapeutics Market Size by Type
6.4 North America Anti-inflammatory Therapeutics Market Size by Application
6.5 North America Anti-inflammatory Therapeutics Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Anti-inflammatory Therapeutics Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Anti-inflammatory Therapeutics Market Size by Type
7.4 Europe Anti-inflammatory Therapeutics Market Size by Application
7.5 Europe Anti-inflammatory Therapeutics Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Anti-inflammatory Therapeutics Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Manufacturers Analysis
8.3 China Anti-inflammatory Therapeutics Market Size by Type
8.4 China Anti-inflammatory Therapeutics Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Anti-inflammatory Therapeutics Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Anti-inflammatory Therapeutics Market Size by Type
9.4 APAC (excl. China) Anti-inflammatory Therapeutics Market Size by Application
9.5 APAC (excl. China) Anti-inflammatory Therapeutics Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 Latin America
10.1 Latin America Anti-inflammatory Therapeutics Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Anti-inflammatory Therapeutics Market Size by Type
10.4 Latin America Anti-inflammatory Therapeutics Market Size by Application
10.5 Latin America Anti-inflammatory Therapeutics Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type
11.4 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application
11.5 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Anti-inflammatory Therapeutics Market Revenue by Key Manufacturers (2021-2025)
12.2 Anti-inflammatory Therapeutics Competitive Landscape Analysis and Market Dynamic
12.2.1 Anti-inflammatory Therapeutics Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 AbbVie
13.1.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 AbbVie Anti-inflammatory Therapeutics Product Portfolio
13.1.3 AbbVie Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Johnson & Johnson Anti-inflammatory Therapeutics Product Portfolio
13.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 Amgen Inc
13.3.1 Amgen Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Amgen Inc Anti-inflammatory Therapeutics Product Portfolio
13.3.3 Amgen Inc Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 AstraZeneca PLC
13.4.1 AstraZeneca PLC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 AstraZeneca PLC Anti-inflammatory Therapeutics Product Portfolio
13.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 Pfizer, Inc
13.5.1 Pfizer, Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Pfizer, Inc Anti-inflammatory Therapeutics Product Portfolio
13.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 Novartis
13.6.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Novartis Anti-inflammatory Therapeutics Product Portfolio
13.6.3 Novartis Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 Roche
13.7.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Roche Anti-inflammatory Therapeutics Product Portfolio
13.7.3 Roche Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 Sanofi
13.8.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Sanofi Anti-inflammatory Therapeutics Product Portfolio
13.8.3 Sanofi Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 Merck
13.9.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Merck Anti-inflammatory Therapeutics Product Portfolio
13.9.3 Merck Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 GlaxoSmithKline Anti-inflammatory Therapeutics Product Portfolio
13.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.11 Sun Pharmaceutical Industries Ltd
13.11.1 Sun Pharmaceutical Industries Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Portfolio
13.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.12 TEVA
13.12.1 TEVA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 TEVA Anti-inflammatory Therapeutics Product Portfolio
13.12.3 TEVA Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis
14.1 Anti-inflammatory Therapeutics Industry Chain Analysis
14.2 Anti-inflammatory Therapeutics Industry Raw Material and Suppliers Analysis
14.2.1 Anti-inflammatory Therapeutics Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Anti-inflammatory Therapeutics Typical Downstream Customers
14.4 Anti-inflammatory Therapeutics Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Loading...

In this report,

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings